CNS Oncology

Aims & Scope

Tumors of the central nervous system (CNS) are the sixth most common form of cancer in adults and the most common form of solid cancer in children in the USA.

Mortality rates remain high - primary CNS tumors are the second and fourth leading cause of cancer mortality in people under the ages of 34 and 54 years, respectively.

Unfortunately, the prognosis for patients with malignant gliomas (the most common form of primary brain tumor) is largely unchanged from two decades ago, with survival being less than a year from diagnosis.

Consequently, there is an urgent need to both develop effective new treatments and further the understanding of the biology for tumors arising in the CNS.

CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice

  Citation: 196

  Authors: Ugonma N, Patrick Y

• Lipid metabolism emerges as a promising target for malignant glioma therapy

  Citation: 164

  Authors: Deliang, Erica Hlavin, Arnab

• Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors

  Citation: 143

  Authors: David E, Achal Singh, Lesli A, Kimberly C, Najee, Garni, Daniel F, Tiffany, Richard B, Victoria M, Minhdan, Judy D, Annie, Jaya, Marlon, Sandeep C, Santosh

• Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

  Citation: 131

  Authors: Ilaria, Enrico, Alicia, Vincenzo Di, Lidia, Raffaele, Alba A

• Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma

  Citation: 111

  Authors: Kan V, Gabriele

• Optic pathway gliomas: a review

  Citation: 100

  Authors: Iris, Uri, Tarik, Arun, Eric

• Symptom management and quality of life in glioma patients

  Citation: 87

  Authors: Florien W, Martin, Jaap C, Irma M, Jan J

• Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas

  Citation: 85

  Authors: Susannah, Stuart A

• Pleomorphic xanthoastrocytoma: a brief review

  Citation: 83

  Authors: Nawal, Nupur, Tim J, Kwok L, Christina L, Nitin R, James, Priya, Rimas V

• <i>BRAF</i> -V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors

  Citation: 82

  Authors: Ashley, Yazmin